Urinary tract infections in children

The Kelalis-King-Belman Textbook of Clinical Pediatric Urology, Fifth Edition

Volumn , Issue , 2006, Pages 103-166

  Pohl, Hans G ^a   Rushton, H Gil ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 43049085267     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (450)

1. Abbott GD. Neonatal bacteriuria: a prospective study in 1,460 infants. BMJ 1972; 1(795):267-9.
2. O'Dougherty NJ. Urinary tract infection in the neonatal period and later in infancy. In: Urinary Tract Infection. London: Oxford University Press, 1968.
3. Littlewood JM, Kite P, Kite BA. Incidence of neonatal urinary tract infection. Arch Dis Child 1969; 44:617.
4. Stamey TA. Urinary infections in infancy and childhood. In: Pathogenesis and Treatment of Urinary Tract Infections. Baltimore: Williams and Wilkins, 1980.
5. Jodal U. The natural history of bacteriuria in childhood. Infect Dis Clin North Am 1987; 1:713-29.
6. Ginsburg CM, McCracken GH Jr. Urinary tract infections in young infants. Pediatrics 1982; 69(4):409-12.
7. Majd M, Rushton HG, Jantausch B et al. Acute febrile urinary infection in children: a prospective clinical, laboratory, and imaging study. J Pediatr 1991; 119:578.
8. Bergstrom T, Larson H, Lincoln K et al. Studies of urinary tract infections in infancy and childhood. XII. Eighty consecutive patients with neonatal infection. J Pediatr 1972; 80(5):858-66.
9. Drew JH, Acton CM. Radiological findings in newborn infants with urinary infection. Arch Dis Child 1976; 51:628-30.
10. Wiswell TE, Smith FR, Bass JW. Decreased incidence of urinary tract infections in circumcised male infants. Pediatrics 1985; 75(5):901-3.
11. Winberg J, Andersen HJ, Bergstrom T et al. Epidemiology of symptomatic urinary tract infection in childhood. Acta Paediatr Scand 1974; 252(Suppl):1.
12. Kunin CM. The natural history of recurrent bacteriuria in schoolgirls. N Engl J Med 1970; 282(26):1443-8.
13. Savage JP. The deleterious effect of constipation upon the reimplanted ureter. J Urol 1973; 109(3):501-3.
14. Saxena SR, Collis A, Laurence BM. Bacteriuria in preschool children. Lancet 1974; 2:517.
15. Newcastle Asymptomatic Bacteriuria Research Group. Asymptomatic bacteriuria in school children in Newcastle-upon-Tyne. Arch Dis Child 1975; 50:90.
16. Lindberg U, Claesson I, Hanson LA et al. Asymptomatic bacteriuria in school girls: I. Clinical and laboratory findings. Acta Paediatr Scand 1975; 64:425.
17. Savage DCL, Wilson MI, McHardy M et al. Covert bacteriuria of childhood: a clinical and epidemiological study. Arch Dis Child 1973; 48:8.
18. Hellstrom A, Hanson E, Hansson S, Hjalmas K, Jodal U. Association between urinary symptoms at 7 years old and previous urinary tract infection. Arch Dis Child 1991; 66(2):232-4.
19. Marild S, Jodal U. Incidence rate of first-time symptomatic urinary tract infection in children under 6 years of age. Acta Paediatr 1998; 87:549-52.
20. Gillenwater JY, Harrison RB, Kunin CM. Natural history of bacteriuria in schoolgirls. A long-term case-control study. N Engl J Med 1979; 301(8):396-9.
21. Martinell J, Jodal U, Lidin-Janson G. Pregnancies in women with and without renal scarring after urinary infections in childhood. BMJ 1990; 300(6728):840-4.
22. Martinell J, Lidin-Janson G, Jagenburg R et al. Girls prone to urinary infections followed into adulthood. Indices of renal disease. Pediatr Nephrol 1996; 10(2):139-42.
23. Brook I. Anaerobes as a cause of urinary tract infection in children [Letter]. Lancet 1981; 1(8224):835.
24. Granoff DM, Roskes S. Urinary tract infection due to Haemophilus influenzae, type b. J Pediatr 1974; 84(3):414-16.
25. Rytand DA, Spreiter S. Prognosis in postural (orthostatic) proteinuria: forty to fifty-year follow-up of six patients after diagnosis by Thomas Addis. N Engl J Med 1981; 305(11):618-21.
26. Lindberg U, Hanson LA, Lidin-Janson G et al. Asymptomatic bacteriuria in school girls: II. Differences in E. coli causing asymptomatic and symptomatic bacteriuria. Acta Paediatr Scand 1975; 64:432.
27. Kaijser B. Immunology of Escherichia coli K antigen and its relation to urinary tract infections in children. Lancet 1977; 1:633.
28. Vaisanen-rhen V, Elo J, Vaisanen E et al. P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun 1984; 43:149-55.
29. Yamamoto S, Nakata K, Yuri K et al. Assessment of the significance of virulence factors of uropathogenic Escherichia coli in experimental urinary tract infection in mice. Microbiol Immunol 1996; 40(9):607-10.
30. Fussell EN, Kaack MB, Cherry R, Roberts JA. Adherence of bacteria to human foreskins. J Urol 1988; 140(5):997-1001.
31. Glauser MP, Lyons JM, Brande AI. Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. J Clin Invest 1978; 61:403.
32. Gillenwater JYJ. Detection of urinary leukocytes by chemstrip-1. J Urol 1981; 125:383.
33. Fussell EN, Kaack MB, Cherry R et al. Bacteriuria in families of girls with recurrent bacteriuria. Clin Pediatr 1977; 16:1132.
34. Malvey MA, Lopez-Bondo Y, Wilson C et al. Induction and evasion of host defenses by type-1 piliated uropathogenic Escherichia coli. Science 1998; 282:1494-7.
35. Blomfield IC. The regulation of pap and type 1 fimbriation in Escherichia coli. Adv Microb Physiol 2001; 45:1-49.
36. Hagberg L, Hull R, Hull S et al. Contribution of adhesion to bacterial persistence in mouse urinary tract. Infect Immun 1983; 40:265-72.
37. Connell I, Agace W, Klemm P et al. Type-1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci USA 1996; 93(18): 9827-32.
38. Marild S, Jodal U, Orskov I et al. Special virulence of Escherichia coli O1:K1:H7 clone in acute pyelonephritis. J Pediatr 1989; 115:40-5.
39. Gunther NW 4th, Lockatell V, Johnson DE, Mobley HL. In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection. Infect Immun 2001; 69:2838-46.
40. Kallenius G, Mollby R, Svensson SB et al. The pK antigen as receptor for the hemagglutination of pyelonephritogenic Escherichia coli. FEMS Microbiol Lett 1980; 7:297.
41. Leffler H, Svanborg-Eden C. Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes. FEMS Microbiol Lett 1980; 8:127.
42. Lomberg H. Properties of Escherichia coli in patients with renal scarring. J Infect Dis 1989; 159:579-82.
43. James-Ellison MY, Roberts R, Verrier-Jones K, Williams JD, Topley N. Mucosal immunity in the urinary tract: changes in sIgA, FSC, and total IgA with age and in urinary tract infection. Clin Nephrol 1997; 48(2):69-78.
44. Kallenius G, Mollby R, Svenson SB et al. Occurrence of P-fimbriated Escherichia coli in urinary tract infections. Lancet 1981; 2(8260-61):1369-72.
45. Roberts JA, Suarez GM, Kaack B et al. Experimental pyelonephritis in the monkey VII: ascending pyelonephritis in the absence of vesicoureteral reflux. J Urol 1985; 133:1068.
46. Daigle F, Harel J, Fairbrother JM et al. Expression and detection of pap-, sfa-, and afa-encoded fimbrial adhesin systems among uropathogenic Escherichia coli. Can J Microbiol 1994; 40(4):286.
47. Johanson M, Plos K, Machlund BI, Svanborg C. Pap, papG, and prsG DNA sequences in Escherichia coli from the fecal flora and the urinary tract. Microb Pathog 1993; 15(2):121-9.
48. Roberts JA. Factors predisposing to urinary tract infections in children. Pediatr Nephrol 1996; 10(4):517.
49. Perugini MK, Vidotto MC. Frequency of pap and pil operons in Escherichia coli strains associated with urinary infections. Braz J Med Biol Res 1996; 29(3):351-7.
50. Bartkova G, Ciznar I, Lehotska V et al. Characterization of adhesion associated surface properties of uropathogenic Escherichia coli. Folia Microbiol 1994; 39(5):373.
51. Schlager TA, Whittam TS, Hendley JO et al. Comparison of expression of virulence factors by Escherichia coli causing cystitis and E. coli colonizing the periurethra of healthy girls. J Infect Dis 1995; 172(3):772-7.
52. O'Hanley P, Lark D, Falkow S, Schoolnik G. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/C mice. Clin Invest 1985; 75:347.
53. Majd M, Rushton HG, Jantausch B, Wiedermann BL. Relationship among vesicoureteral reflux, P-fimbriated Escherichia coli, and acute pyelonephritis in children with febrile urinary tract infection. J Pediatr 1991; 119(4): 578-85.
54. Rushton HG, Majd M, Jauntausch B et al. Renal scarring following reflux and non-reflux pyelonephritis in children: evaluation with 99m-technetium dimercaptosuccinic acid distribution patterns in acute pyelonephritis. J Urol 1992; 147(5):1327-32.
55. Horowitz MA, Silverstein SC. Influence of Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest 1980; 65:82.
56. Svanborg-Eden C, Hagberg L, Hull R et al. Bacterial virulence versus host resistance in the urinary tracts of mice. Infect Immun 1987; 55:124.
57. Siegfried L, Kmetkova M, Pazova H, Molokacova M, Filka J. Virulence-associated factors in Escherichia coli strains isolated from cultures of blood specimens from urosepsis and non-urosepsis patients. Microbiologia 1994; 10(3):249.
58. Blanco M, Blanco JE, Alonso MP, Blanco J. Virulence factors and O groups of Escherichia coli strains isolated from cultures of blood specimens from urosepsis and non urosepsis patients. Microbiologia 1994; 10(3):249.
59. Blanco M, Blanco JE, Alonso MP, Blanco J. Virulence factors and O groups of Escherichia coli isolates from patients with acute pyelonephritis, cystitis, and asymptomatic bacteriuria. Eur J Epidemiol 1996; 12(2):191.
60. Kaijser B. Immunology of Escherichia coli: K antigen and its relation to urinary-tract infection. J Infect Dis 1973; 127(6):670-7.
61. Waalwijk C, MacLaren DM, de Graaff J. In vivo function of hemolysin in the nephropathogenicity of Escherichia coli. Infect Immun 1983; 42:245-9.
62. Williams PH. Novel iron uptake system specified by Col V plasmids: an important component in the virulence of invasive strains of Escherichia coli. Infect Immun 1979; 26:295.
63. Carbonetti NH, Boonchai S, Paary SH et al. Aerobactinmediated iron uptake by Escherichia coli isolates from human extraintestinal infections. Infect Immun 1986; 51:966.
64. Jacobson SN, Hammarlind M, Lidelfeldt K. Incidence of aerobactin-positive Escherichia coli strains in patients with symptomatic urinary tract infection. Eur J Clin Microbiol Infect Dis 1988; 7:630.
65. McCabe WR, Kaijser B, Olling S et al. Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis 1978; 138:33-41.
66. Olling S, Hansson LA, Holmgren JU et al. The bactericidal effect of normal human serum on E. coli strains from normals and from patients with urinary tract infections. Infect Immun 1973; 1:24.
67. Arthur M, Johnson CE, Rubin RH. Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun 1989; 57:303-13.
68. Topley N, Steadman R, Mackenzie R. Type 1 fimbriate strains of Escherichia coli initiate renal parenchymal scarring. Kidney Int 1998; 4:609-16.
69. Mizunoe Y, Matsumoto T, Sakumoto M et al. Renal scarring by mannose-sensitive adhesin of Escherichia coli type 1 pili. Nephron 1997; 77(4):412-16.
70. Mundi H, Bjorksten B, Svanborg C et al. Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring. Infect Immun 1991; 59(11):4168
71. Hagberg L, Jodal U, Korkonen T et al. Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun 1981; 31:564-70.
72. Svanborg-Eden C, Eriksson B, Hanson LA. Adhesion of Escherichia coli to human uroepithelial cells in vitro. Infect Immun 1977; 21:767-74.
73. Anderson P, Engberg I, Lidin-Janson G. Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun 1991; 59:2915-21.
74. Bollgren I, Winburg J. The periurethral aerobic bacterial flora in girls highly susceptible to urinary infections. Acta Paediatr Scand 1976; 65:81.
75. Stamey TA, Timothy M, Millar M et al. Recurrent urinary infections in adult women. The role of introital enterobacteria. Calif Med 1971; 115:1.
76. Leadbetter G Jr, Slavins S. Pediatric urinary tract infections: significance of vaginal bacteria. Urology 1974; 3:581.
77. Stamey TA. The role of introital bacteria in recurrent urinary infections. J Urol 1973; 109:467.
78. Gruneberg RN. The relationship of infecting organisms to fecal flora in patients with symptomatic urinary infection. Lancet 1969; 2:766.
79. Patrick MJ. The influence of maternal renal infection on the foetus and infant. Arch Dis Child 1967; 42:208.
80. Gareau FE, Mackel DC, Boring JR et al. The acquisition of fecal flora by infants from their mothers during birth. J Pediatr 1959; 54:313.
81. Chan RCY, Bruce AW, Reid G. Adherence of cervical, vaginal and distal urethral normal microbial flora to human uroepithelial cells and inhibition of adherence of gram-negative uropathogens by competitive exclusion. J Urol 1984; 131:596.
82. Chan RCY, Reid G, Irvin RT et al. Competitive exclusion of uropathogens from human uroepithelial cells by lactobacillus whole cells and cell wall fragments. Infect Immun 1985; 47:84.
83. Marild S, Jodal U, Mangelus L. Medical histories of children with acute pyelonephritis compared with controls. J Pediatr Infect Dis 1989; 8:511.
84. Wold AE, Caugant DA, Lidin-Janson G et al. Resident E. coli strains frequently display uropathogenic characteristics. J Infect Dis 1992; 165(1):46.
85. Plos K, Connell H, Jodal U et al. Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J Infect Dis 1995; 171(3):625-31.
86. Bollgren I, Winburg J. The periurethral aerobic bacterial flora in healthy boys and girls. Acta Paediatr Scand 1976; 65:74.
87. Brumfitt W, Gargan RA, Hamilton-Miller JM. Periurethral enterobacterial carriage preceding urinary infection. Lancet 1987; 1(8537):824-6.
88. Rushton HG, Majd M. Pyelonephritis in male infants: how important is the foreskin? J Urol 1992; 148:733.
89. Wiswell TE, Enzenauer RW, Holton ME, Cornish JD, Hankins CT. Declining frequency of circumcision: implications for changes in the absolute incidence and male to female sex ratio of urinary tract infections in early infancy. Pediatrics 1987; 79(3):338-42.
90. Wiswell TE, Hachey WE. Urinary tract infections and the uncircumcised state: an update. Clin Pediatr 1993; 32(3):130-4.
91. Wiswell TE, Roscelli JD. Corroborative evidence for the decreased incidence of urinary tract infection in circumcised male infants. Pediatrics 1986; 78:66.
92. Kim KK. Preputial condition and urinary tract infections. J Korean Med Sci 1996; 11(4):332.
93. Roberts JA. Neonatal circumcision: an end to the controversy? South Med J 1996; 89(2):167-71.
94. Graham JB, King LR, Kropp KA et al. The significance of distal urethral narrowing in young girls. J Urol 1967; 97:1045.
95. Immergut MA, Wahman GE. The urethral caliber of female children with urinary tract infection. J Urol 1968; 99:189.
96. Kallenius G, Winberg J. Bacterial adherence to periurethral epithelial cells in girls prone to urinary-tract infections. Lancet 1978; 2(8089):540-3.
97. Svanborg-Eden C, Jodal U. Attachment of Escherichia coli to sediment epithelial cells from UTI prone and healthy children. Infect Immun 1979; 26:837.
98. Hansen A, Hansen B, Dahm TL. Urinary tract infection, day wetting and other voiding symptoms in sevento eightyear-old Danish children. Acta Pediatr 1997; 86:1135-9.
99. Allen TD. The non-neurogenic bladder. J Urol 1977; 117:232.
100. Hansson S. Urinary incontinence in children and associated problems. Scand J Urol Nephrol Suppl 1992; 141:47-55.
101. Hansson S, Hjalmas K, Jodal U, Sixt R. Lower urinary tract dysfunction in girls with untreated asymptomatic or covert bacteriuria. J Urol 1990; 143:333-5.
102. Hinman F. Urinary tract damage in children who wet. Pediatrics 1974; 54(2):143-50.
103. Koff SA, Murtagh DS. The uninhibited bladder in children: effect of treatment on recurrence of urinary infection and on vesicoureteral reflux resolution. J Urol 1983; 130(6):1138-41.
104. Snodgrass W. Relationship of voiding dysfunction to urinary tract infection and vesicoureteral reflux in children. Urology 1991; 38:341.
105. Van Gool J, Tanagho E. External sphincter activity and urinary tract infections in girls. Urology 1977; 10:348.
106. Mayo ME, Burns MW. Urodynamic studies in enuresis and the non-neurogenic bladder. Br J Urol 1990; 65:641.
107. Chen JJ, Mao W, Homayoon K, Steinhardt GF. A multivariate analysis of dysfunctional elimination syndrome, and its relationships with gender, urinary tract infection and vesicoureteral reflux in children. J Urol 2004; 171(5):1907.
108. van Gool JD. Dysfunctional voiding: a complex of bladder/sphincter dysfunction, urinary tract infections and vesicoureteral reflux. Acta Urolog Belg 1995; 63:27-33.
109. Cox CE, Hinman F. Experiments with induced bacteriuria, vesical emptying, and bacterial growth on the mechanisms of bladder defense to infection. J Urol 1961; 86:739.
110. Schulman SL, Quinn CK, Plachter N, Kodman-Jones C. Comprehensive management of dysfunctional voiding. Pediatrics 1999; 103(3):e31.
111. Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics 1997; 100(2 Pt 1):228-32.
112. De Paepe H, Hoebeke P, Renson C et al. Pelvic-floor therapy in girls with recurrent urinary tract infections and dysfunctional voiding. Br J Urol 1998; 81(Suppl 3):109-13.
113. Koff SA, Lapides J, Piazza DH. Association of urinary tract infection and reflux with uninhibited bladder contractions and voluntary sphincteric obstruction. J Urol 1979; 122(3):373-6.
114. Seruca H. Vesicoureteral reflux and voiding dysfunction: prospective study. J Urol 1989; 142:494.
115. Williams MA, Noe HN, Smith RA. The importance of urinary tract infection in the evaluation of the incontinent child. J Urol 1994; 151(1):188-90.
116. Van Gool JD, Kuijten RH, Donekerwolcke RA et al. Bladder-sphincter dysfunction, urinary infection and vesicoureteral reflux with special reference to cognitive bladder training. Contrib Nephrol 1984; 39:190.
117. Hjalmas K. Functional daytime incontinence: definitions and epidemiology. Scand J Urol Nephrol 1992; 141 (Suppl):39.
118. Van Gool JD, Vijverberg MA, de Jong TP. Functional daytime incontinence: clinical and urodynamic assessment. Scand J Urol Nephrol 1992; 141:58.
119. Wan J, Kaplinsky R, Greenfield S. Toilet habits of children evaluated for urinary tract infection. J Urol 1995; 154(2 Pt 2):797-9.
120. Neumann PZ, DeDomenico IJ, Nogrady MB. Constipation and urinary tract infection. Pediatrics 1973; 52(2):241-5.
121. O'Regan S, Yazbeck S, Schick E. Constipation, bladder instability, urinary tract infection syndrome. Clin Nephrol 1985; 23:152.
122. Koff SA, Wagner TT, Jayanthi VR. The relationship among dysfunction elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children. J Urol 1998; 160:1019-22.
123. Fennell RS, Wilson SG, Garin EH et al. Bacteriuria in families of girls with recurrent bacteriuria. Clin Pediatr 1977; 16:1132.
124. Askari A, Belman AB. Vesicoureteral reflux in black girls. J Urol 1982; 127(4):747-8.
125. Hopkins WJ, Gendron-Fitzpatrick A, Balish E, Uehling DT. Time course and host response to Escherichi coli urinary tract infection in genetically distinct mouse strains. Infect Immun 1998; 66(6):2798-802.
126. Cotton SA, Gbadegesin RA, Williams S et al. Role of TGF-β1 in renal parenchymal scarring following childhood urinary tract infection. Kid Int 2002; 61:61-7.
127. Solari V, Ennis S, Cascio S, Puri P. Tumor necrosis factor-alpha gene polymorphism in reflux nephrapathy. J Urol 2004; 172(4 Pt2): 1604-6; discussion 1606.
128. Ozen S, Alikasifoglu M, Tuncbilek E et al. Polymorphisms in angiotensin converting enzyme gene and reflux nephropathy: a genetic predisposition to scar formation? Nephrol Dial Transplant 1997; 12(9):2031.
129. Erdogan H, Mir S, Serdaroglu E et al. Is ACE gene polymorphism a risk factor for renal scaring with low-grade reflux? Pediatr Nephrol 2004; 19:734-7.
130. Hohenfellner K, Wingen AM, Nauroth O et al. Impact of ACE I/D gene polymorphism on congenital renal malformations. Pediatr Nephrol 2001; 16(4):356
131. Marcus DM. The ABO and Lewis blood-group system. Immunocytochemistry, genetics and relation to human disease. N Engl J Med 1969; 280:994-1006.
132. Navas EL, Venegas MF, Duncan JL et al. Blood group antigen expression on vaginal and buccal epithelial cells and mucus in secretor and nonsecretor women. J Urol 1993; 149:1492.
133. Schaeffer AJ, Navas EL, Venegas MF et al. Variation of blood group antigen expression on vaginal cells and mucus in secretor and nonsecretor women. J Urol 1994; 152(3):859-64.
134. Navas EL, Venegas MF, Duncan JL et al. Blood group antigen expression on vaginal cells and mucus in women with and without a history of urinary tract infections. J Urol 1994; 152(2 Pt 1):345-9.
135. Sheinfeld J, Cordon-Cardo C, Fair WR, Wartinger DD, Rabinowitz R. Association of type 1 blood group antigens with urinary tract infections in children with genitourinary structural abnormalities. J Urol 1990; 144(2 Pt 2):469-73; discussion 474.
136. Jantausch BA, Criss VR, O'Donnell R et al. Association of Lewis blood group phenotypes with urinary tract infection in children. J Pediatr 1994; 124(6):863-8.
137. Albarus MH, Salzano FM, Goldraich NP. Genetic markers and acute febrile urinary tract infection in the first year of life. Pediatr Nephrol 1997; 11(6):691-4.
138. Chick S, Harver MJ, MacKenzie R et al. Modified method for studying bacterial adhesion to isolated uroepithelial cells and uromucoid. Infect and Immun 1981; 34:256.
139. Orskov I, Ferencz A, Orskov F. Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps Type-1 fimbriated Escherichia coli. Lancet 1980; 2:887.
140. Parkkinen J, Virkola R, Korhonen TK. Escherichia coli strains binding neuraminyl α2-3 galactosides. Biochem Biophys Res Commun 1983; 11:456-61.
141. Toma G, Bates J, Kumar S. Uromodulin (Tamm-Horsfall protein) is a leukocyte adhesion molecule. Biochem Biophys Res Commun 1994; 200:275-82.
142. Israele V, Darabi A, McCracken GH Jr. The role of bacterial virulence factors and Tamm-Horsfall protein in the pathogenesis of Escherichia coli urinary tract infection in infants. Am J Dis Child 1987; 141(11):1230-4.
143. Lomberg H, Hanson LA, Jacobsson B et al. Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis. N Engl J Med 1983; 308(20):1189-92.
144. Tomisawa S, Kogure T, Kuroume T et al. P blood group and proneness to urinary tract infections in Japanese children. Scand J Infect Dis 1989; 21:403.
145. Stapleton AE, Stroud MR, Hakomori SI, Stamm WE. The globoseries glycosphingolipid sialosyl galactosyl globoside is found in urinary tract tissues and is a preferred binding receptor in vitro for uropathogenic Escherichia coli expressing pap-encoded adhesins. Infect and Immun 1998; 66(8):3856-61.
146. Bergsten, G, Samuelsson M, Wullt B et al. PapG-dependent adherence breaks mucosal inertia and triggers the innate host response. J Infect Dis 2004; 189(9):1734-42.
147. Hellerstein S, Kennedy E, Nussbaum L, Rice K. Localization of the site of urinary tract infections by means of antibody-coated bacteria in the urinary sediments. J Pediatr 1978; 92(2):188-93.
148. Thomas V, Shelokov A, Forland M. Antibody-coated bacteria in the urine and the site of urinary-tract infection. N Engl J Med 1974; 290:588-90.
149. Hanson LA, Ahlstedt S, Fasth A et al. Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections. J Infect Dis 1977; 136(Suppl):S144-9.
150. Hopkins WJ, Xing Y, Dahmer LA, Balish E, Uehling DT. Western blot analysis of anti-Escherichia coli serum immunoglobulins in women susceptible to recurrent urinary tract infections. J Infect Dis 1995; 172(6):1612-6.
151. Mattsby-Baltzer I, Claesson I, Hanson LA et al. Antibodies to lipid A during urinary tract infection. J Infect Dis 1981; 144(4):319-28.
152. Sohl-Akerlund A, Ahlstedt S, Hanson LA et al. Antibody responses in urine and serum against Escherichia coli in childhood urinary tract infections. Acta Pathol Microbiol 1979; 87:29.
153. Rene P, Silverblatt FJ. Serological response to Escherichia coli in pyelonephritis. Infect Immun 1982; 37:749.
154. Svanborg-Eden C, Svennerholm AM. Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells. Infect Immun 1978; 22:790.
155. Wold AE, Mestecky J, Svanborg-Eden C. Agglutination of E. coli by secretory IgA-a result of interaction between bacterial mannose-specific adhesins and immunoglobulin carbohydrate? Monogr Allergy 1988; 24:307-9.
156. Clark H, Ronal AR, Turck M. Serum antibody response in renal versus bladder bacteria. J Infect Dis 1971; 123:539.
157. Uehling DT, Steihm ER. Elevated urinary secretory IgA in children with urinary tract infection. Pediatrics 1971; 47(1):40-6.
158. Fleidner M, Mehls O, Rauterberg EW et al. Urinary SIgA in children with urinary tract infection. J Pediatr 1986; 109:416.
159. Kaijser B, Larsson P, Olling S. Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity. Infect Immun 1983; 20:78-81.
160. Uehling DT, Jensen J, Balish E. Vaginal immunization against urinary tract infection. J Urol 1982; 128:1382.
161. Uehling DT, Mizutani K, Balish E. Effect of immunization on bacterial adherence to urothelium. Invest Urol 1978; 16:145.
162. Coppa GV, Gabrielli O, Giorgi P et al. Preliminary study of breastfeeding and bacterial adhesion to uroepithelial cells. Lancet 1990; 335(8689):569-71.
163. Hahn H, Kaufmann SHE. The role of cell-mediated immunity in bacterial infections. Rev Infect Dis 1981; 3:1221.
164. Hjelm EM. Local cellular immune response in ascending urinary tract infection: occurrence of T-cells, immunoglobulin-producing cells, and Ia-expressing cells in rat urinary tract tissue. Infect Immun 1984; 44:627.
165. Miller TE, Scott L, Stewart E et al. Modification by suppressor cells and serum factors of the cell-mediated immune response in experimental pyelonephritis. J Clin Invest 1978; 61:864.
166. Svanborg-Eden C, Briles D, Hagberg L, McGhee J, Michael S. Genetic factors in host resistance to urinary tract infection. Infection 1984; 12:118-23.
167. Svensson M, Lindstedt R, Radin N et al. Epithelial glycosphingolipid expression as a determinant of bacterial adherence and cytokine production. Infect Immun 1994; 62:4404-10.
168. Hedges S, Svensson M, Svanborg C. Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun 1992; 60:1295-301.
169. Agace W, Hedges S, Ceska M et al. IL-8 and the neutrophil response to mucosal Gram negative infection. J Clin Invest 1993; 92:780-5.
170. Mannhardt W, Becker A, Putzer M et al. Host defense within the urinary tract. I. Bacterial adhesion initiates an uroepithelilal defense mechanism. Pediatr Nephrol 1996; 10(5):568-72.
171. Takeda K, Akira S. Toll receptors and pathogen resistance. Cell Microbiol 2003; 5(3):143-53.
172. Hang L, Frendeus B, Godaly G et al. Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J Infect Dis 2000; 182(6):1738-48.
173. Pecha B, Low D, O'Hanley P. Gal-Gal pili vaccines prevent pyelonephritis by piliated E. coli in a murine model. J Clin Invest 1989; 83:2102.
174. Roberts JA, Hardaway K, Kaack B et al. Prevention of pyelonephritis by immunization with p-fimbria. J Urol 1984; 131:602.
175. Roberts JA, Kaack MB, Baskin G et al. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein. J Urol 2004; 171(4):1682.
176. Silverblatt FJ, Weinstein R, Rene P. Protection against experimental pyelonephritis by antibodies to pili. Scand J Infect Dis 1982; 33:79.
177. Thankavel K, Madison B, Ikeda T et al. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domainspecific antibody to confer protection against experimental urinary tract infection. J Clin Invest 1997; 100(5):1123-36.
178. Uehling DT, Hopkins WJ, Balish E, Xing Y, Heisey DM. Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial. J Urol 1997; 157(6):2049-52.
179. Nayir A, Evare S, Sinin A et al. The effects of vaccination with inactivated uropathogenic bacteria in recurrent urinary tract infections in children. Vaccine 1995; 13(11):987-90.
180. Smellie JM, Gruneberg RN, Leakey A, Atkin WS. Longterm low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: clinical aspects. BMJ 1976; 2(6029):203-6.
181. Bailey RR. The relationship of vesico-ureteric reflux to urinary tract infection and chronic pyelonephritis-reflux nephropathy. Clin Nephrol 1973; 1:132.
182. Ransley PG. Vesicureteral reflux: continuing surgical dilemma. Urology 1978; 12:246.
183. Rushton HG. The evaluation of acute pyelonephritis and renal scarring with technetium 99m-dimercaptosuccinic acid renal scintigraphy: evolving concepts and future directions. Pediatr Nephrol 1997; 11:108-20.
184. Naseer SR, Steinhardt GF. New renal scars in children with urinary tract infections, vesicoureteral reflux and voiding dysfunction: a prospective evaluation. J Urol 1997; 158(2):566-8.
185. Hobermann A, Wald ER. Urinary tract infections in young febrile children. Pediatr Infect Dis 1997; 16(1):11-17.
186. Dickinson JA. Incidence and outcome of symptomatic urinary tract infection in children. BMJ 1979; 1:1330-2.
187. Heale WF, Weldone DP, Hewstone AS. Reflux nephropathy: presentation or urinary infection in children. Med J Aust 1977; 1:1138.
188. Corman LI, Forsage WS, Kotchmar GS. Simplified urinary microscopy to detect significant bacteriuria. Pediatrics 1982; 70:133.
189. Pryles CV, Eliot CR. Pyuria and bacteriuria in infants and children: the value of pyuria as a diagnostic criterion of urinary tract infections. Am J Dis Chil 1965; 110:628.
190. Stamm WE. Measurement of pyuria and its relationship to bacteriuria. Am J Med 1983; 75(Suppl):53.
191. Robins DG, Rogers KB, White RHR. Urine microscopy as an aid to detection of bacteriuria. Lancet 1975; 1:476.
192. Hoberman A, Wald ER, Reynolds EA, Penchansky L, Charron M. Pyuria and bacteriuria in urine specimens obtained by catheter from young children with fever. J Pediatr 1994; 124(4):513-19.
193. Landau D, Turner ME, Brennan J, Majd M. The value of urinalysis in differentiating acute pyelonephritis from lower urinary tract infection in febrile infants. Pediatr Infect Dis 1994; 13:777.
194. Kusumi RK, Glover PJ, Kunin CM. Rapid detection of pyuria by leukocyte esterase activity. JAMA 1981; 254:1653.
195. James GP, Paul KL, Fuller JB. Urinary nitrate in urinary tract infection. Am J Clin Pathol 1978; 70:671.
196. Pezzlo M. Detection of urinary tract infection by rapid methods. Clin Microbiol Rev 1988; 1:268.
197. Bolann BJ, Sandberg S, Digranes A. Implications of probability analysis for interpreting results of leukocyte esterase and nitrite test strips. Clin Chem 1989; 35:1663.
198. Tomlinson PA, Smellie JM, Prescod N et al. Differential excretion of urinary proteins in children with vesicoureteric reflux and reflux nephropathy. Pediatr Nephrol 1994; 8:21.
199. Miyakita H, Puri P. Urinary levels of N-acetyl-beta-D-glucosaminidase-a simple marker for predicting tubular damage in higher grades of vesicoureteric reflux. Eur Urol 1994; 25:135.
200. Taha AS, Grant V, Kelly RW. Urinalysis for interleukin-8 in the non-invasive diagnosis of acute and chronic inflammatory diseases. Postgrad Med J 2003; 79(929):159-63.
201. Nelson JD, Peters PC. Suprapubic aspiration of urine in preterm and term infants. Pediatrics 1965; 36:132.
202. Smellie JM, Hodson CJ, Edwards D et al. Clinical and radiological features of urinary infection in childhood. BMJ 1964; 2:1222.
203. Hoberman A, Chao HP, Keller DM et al. Prevalence of urinary tract infection in febrile infants. J Pediatr 1993; 123(1):17-23.
204. Crain EF, Gershel JC. Urinary tract infections in febrile infants younger than 8 weeks of age. Padiatrics 1990; 86(3):363-7.
205. Klevan JL, De Jong AR. Urinary tract symptoms and urinary tract infection following sexual abuse. Am J Dis Child 1990; 144(2):242-4.
206. Jodal U. Urinary tract infection in children. In: Holliday M, Barratt TM, Avner Ed, eds. Pediatric Nephrology, 3rd edn. Baltimore, MD: Williams and Wilkins, 1994.
207. McLachlan M, Mellor S, Verrier-Jones E et al. Urinary tract infection in school girls with covert bacteriuria. Arch Dis Child 1975; 50:253.
208. Lindberg U, Claesson I, Hanson LA et al. Asymptomatic bacteriuria in schoolgirls: VIII. Clinical course during a three-year follow-up. J Pediatr 1978; 92:194.
209. Cardiff-Oxford Bacteriuria Study Group. Sequelae of covert bacteriuria in school children. Lancet 1978; 1:889.
210. Svanborg-Eden C, Hanson CA, Jodal U, Lindberg U, Sohl-Akerlund A. Variable adherence to normal human urinary tract epithelial cells of Escherichia coli strains associated with various forms of urinary infection. Lancet 1976; 11:490.
211. Linshaw M. Asymptomatic bacteriuria and vesicoureteral reflux in children. Kidney Int 1996; 50:312.
212. Uehling DT, King LR. Secretory immunoglobulin A excretion in cystitis cystica. Urology 1973; 1:305.
213. Roberts JA. Etiology and pathophysiology of pyelonephritis. Am J Kidney Dis 1991; 17:1.
214. Roberts JA. Mechanisms of renal damage in chronic pyelonephritis (reflux neuropathy). In: Current Topics in Pathology. Heidelberg: Springer, 1995.
215. Kaack MB, Dowling KJ, Patterson GM, Roberts JA. Immunology of pyelonephritis: E. coli causes granulocytic aggregation and renal ischemia. J Urol 1986; 136:1117-22.
216. Hill GS, Clarck RL. A comparative angiographic, microangiographic, and histologic study of experimental pyelonephritis. Invest Radiol 1972; 7:33.
217. Androulakakis PA, Ransley PG, Risdon RA. Microvascular changes in the early stage of reflux pyelonephritis: an experimental study in the pig kidney. Eur Urol 1987; 13:219-23.
218. Majd M, Rushton HG. Renal cortical scintigraphy in the diagnosis of acute pyelonephritis. Semin Nucl Med 1992; 22:98-111.
219. Roberts KB, Charney E, Sweren RJ et al. Urinary tract infection in infants with unexplained fever: a collaborative study. J Pediatr 1983; 103(6):864-7.
220. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320(6):365-75.
221. Dakin HD. On the use of certain antiseptic substances in the treatment of infected wounds. BMJ 1915; 2:318-20.
222. Ginsburg I, Kohen R. Cell damage in inflammatory and infectious sites might involve a coordinated 'cross-talk' among oxidants, microbial haemolysins and ampiphiles, cationic proteins, phospholipases, fatty acids, proteinases, and cytokines (an overview). Free Rad Res 1995; 22(6):489-517.
223. Roberts JA, Ruth JK, Dominique GL et al. Immunology of pyelonephritis in the primate model: effect of superoxide dismutase. J Urol 1982; 128:1394.
224. Pohl HG, Rushton HG, Park JS et al. Adjunctive oral corticosteroids reduce renal scarring: the piglet model of reflux and acute experimental pyelonephritis. J Urol 1999; 162(3 Pt 1):815-20.
225. Busch R, Huland H. Correlation of symptoms and results of direct bacterial localization in patients with urinary tract infections. J Urol 1984; 132(2):282-5.
226. Stamey TA, Govan DE, Palmer JM. The localization and treatment of urinary tract infections: the role of bactericidal levels as opposed to serum levels. Medicine 1965; 44:1.
227. Fairley KF, Carson NE, Gutch RC et al. Site of infection in acute urinary-tract infection in general practice. Lancet 1971; 2(7725):615-18.
228. Handmaker H. Nuclear renal imaging in acute pyelonephritis. Semin Nucl Med 1982; 12:246.
229. Traisman ES, Conway JJ, Traisman HS. The localization of urinary tract infection with 99m Tc glucoheptonate scintigraphy. Pediatr Radiol 1986; 16:403.
230. Sty JR, Wells RG, Starshak RJ, Schroeder BA. Imaging in acute renal infection in children. AJR Am J Roentgenol 1987; 148(3):471-7.
231. Rushton HG, Majd M, Chandra R, Yim D. Evaluation of 99m-technetium-dimercaptosuccinic acid renal scans and experimental acute pyelonephritis in piglets. J Urol 1988; 140:1169-74.
232. Parkhouse HF, Godley ML, Cooper J, Risdon RA, Ransley PG. Renal imaging with 99m-Tc-labelled DMSA in the detection of acute pyelonephritis: an experimental study in the pig. Nucl Med Commun 1989; 30:1219.
233. Rushton HG, Majd M. Dimercaptosuccinic acid renal scintigraphy for the evaluation of pyelonephritis and scarring: a review of experimental and clinical studies. J Urol 1992; 148(2 Pt 2):1726-32.
234. Tarkington MA, Fildes RD, Levin K et al. High resolution single photon emission computerized tomography (SPECT) 99m-technetium-dimercaptosuccinic acid renal imaging: a state of the art technique. J Urol 1990; 144:598-600.
235. Itoh K, Asano Y, Tsukamoto E et al. Single photon emission computed tomography with Tc-99m-dimercaptosuccinic acid in patients with upper urinary tract infection and/or vesicoureteral reflux. Ann Nucl Med 1991; 5(1):29-34.
236. Itoh K, Yamashita T, Tsukamoto E et al. Qualitative and quantitative evaluation of renal parenchymal damage by 99mTc-DMSA planar and SPECT scintigraphy. Ann Nucl Med 1995; 9:23-8.
237. Majd M, Rushton HG, Chandra R et al. 99mTc-DMSA renal cortical scintigraphy for the detection of experimental acute pyelonephritis in piglets: comparison of planar (pinhole) and SPECT imaging. J Nucl Med 1996; 37:1731-4.
238. Bjorgvinsson E, Majd M, Eggli DK. Diagnosis of acute pyelonephritis in children: comparison of sonography and 99m-Tc DMSA scintigraphy. AJR Am J Roentgenol 1991; 157:539.
239. MacKenzie JR, Fowler K, Hollman AS et al. The value of ultrasound in acute urinary tract infection. Br J Urol 1994; 74(2):240.
240. Melis K, Vandevivere J, Hoskens C et al. Early 99m Tcdimercaptosuccinic acid scintigraphy in symptomatic first time urinary tract infection. Acta Pediatr 1992; 85(4):430.
241. Benador D, Benador N, Slosman DO et al. Cortical scintigraphy in the evaluation of renal parenchymal changes in children with pyelonephritis. J Pediatr 1994; 124(1):17-20.
242. Shanon A, Feldman W, McDonald P et al. Evaluation of renal scars by technetium-labeled dimercaptosuccinic acid scan, intravenous urography, and ultrasonography: a comparative study. J Pediatr 1992; 120:399-403.
243. Tasker AD, Lindsell DR, Moncrieff M. Can ultrasound reliably detect renal scarring in children with urinary tract infection? Clin Radiol 1993 47(3):177-9.
244. Yen TC, Chen WP, Chang SL et al. A comparative study of evaluating renal scars by 99m-Tc-DMSA planar and SPECT renal scans, intravenous urography, and ultrasonography. Ann Nucl Med 1994; 8:147-52.
245. Silver TM, Kass EJ, Thornbury JR et al The radiological spectrum of acute pyelonephritis in adults and adolescents. Radiology 1976; 118:65.
246. Piepsz A, Pintelon H, Verboven M, Keuppens F, Jacobs A. Replacing 99mTcm-DMSA for renal imaging? Nucl Med Commun 1992; 13:494-6.
247. Sreenarasimhaiah V, Alon US. Uroradiologic evaluation of children with urinary tract infection: are both ultrasonography and renal cortical scintigraphy necessary? J Pediatr 1995; 127(3):373-7.
248. Lonergan GJ, Pennington DJ, Morrisson JC et al. Childhood pyelonephritis: comparison of gadoliniumenhanced MR imaging and renal vortical scintigraphy for diagnosis. Radiology 1998; 207:377-85.
249. Majd M, Nussbaum-Blask AR, Markle BM et al. Acute pyelonephritis: comparison of diagnosis with 99mTc-DMSA, SPECT, spiral CT, MR imaging, and power Doppler US in an experimental pig model. Radiology 2001; 218(1):101-8.
250. Halevy R, Smolkin V, Bykov S et al. Power Doppler ultrasonography in the diagnosis of acute childhood pyelonephritis. Pediatr Nephrol 2004; 19(9):987-91.
251. Dick PT, Feldman W. Routine diagnostic imaging for childhood urinary tract infections: a systematic overview. J Pediatr 1996; 128(1):15-22.
252. Ransley PG, Risdon RA. Reflux nephropathy: effects of antimicrobial therapy on the evolution of the early pyelonephritic scar. Kidney Int 1981; 20:733-42.
253. Smellie JM, Ransley PG, Normand IC, Prescod N, Edwards D. Development of new renal scars: a collaborative study. BMJ Clin Res Ed 1985; 290(6486):1957-60.
254. Smellie JM, Normand ICS, Katz G. Children with urinary infection: a comparison of those with and without vesicoureteric reflux. Kidney Int 1981; 20:717.
255. Winberg J, Bergstrom T, Jacobsson B. Morbidity, age, and sex distribution, recurrences and renal scarring in symptomatic urinary tract infection in childhood. Kidney Int 1975; 8:S101.
256. Smellie J, Edwards D, Hunter N et al. Vesicoureteral reflux and renal scarring. Kidney Int 1975; 8(Suppl):65.
257. Sargent MA, Stringer DA. Voiding cystourethrography in children with urinary tract infection: the frequency of vesicoureteric reflux is independent of the specialty of the physician requesting the study. AJR Am J Roentgenol 1995; 164(5):1237-41.
258. Koff SA. A practical approach to evaluating urinary tract infections in children. Pediatr Nephrol 1991; 5:398-400.
259. Jerkins GR, Noe HN. Familial vesicoureteral reflux: a prospective study. J Urol 1982; 128:7743.
260. MacKenzie JR. A review of renal scarring in children. Nucl Med Commun 1996; 17:176-90.
261. Ditchfield MR, De Campo JF, Cook DJ et al. Vesicoureteral reflux: an accurate predictor of acute pyelonephritis in childhood urinary tract infection? Radiology 1994; 190(2):413-15.
262. Haycock GB. A practical approach to evaluating urinary tract infection in children. Pediatr Nephrol 1991; 5:401-2.
263. Gleeson FV, Gordon I. Imaging in urinary tract infection. Arch Dis Child 1991; 66(11):1282-3.
264. Verboven M, Ingels M, Delree M, Piepsz A. 99m Tc-DMSA scintigraphy in acute urinary tract infection in children. Pediatr Radiol 1990; 20:540-2.
265. Verber IG, Strudley MR, Meller ST. 99mTc dimercaptosuccinic acid (DMSA) scan as first investigation of urinary tract infection. Arch Dis Child 1988; 63(11):1320-5.
266. Hansson S, Dhamey M, Sigstrom O et al. Dimercaptosuccinic acid scintigraphy instead of voiding cystourethrography for infants with urinary tract infection. J Urol 2004; 172(3):1071-3; discussion 1073-4.
267. Gonzalez E, Papazyan JP, Girardin E. Impact of vesicoureteral reflux on the size of renal lesions after an episode of acute pyelonephritis. J Urol 2005; 173(2):571-4.
268. Nash MA, Siegele RL. Urinary tract infections in infants and children. Adv Pediatr Infect Dis 1996; 11:403-8.
269. AAP Committee on Quality Improvement. Practice parameter: the diagnosis, treatment and evaluation of the initial urinary tract infection in febrile infants and children. Pediatrics 1999; 103:843-52.
270. Gross GW, Lebowitz RL. Infection does not cause reflux. AJR Am J Roentgenol 1981; 137(5):929-32.
271. Craig JC, Knight JF, Sureshkumar P et al. Vesicoureteric reflux and timing of micturating cystourethrography after urinary tract infection. Arch Dis Child 1997; 76(3):275-7.
272. Hellstrom M, Jodal U, Marild S, Wettergren B. Ureteral dilatation in children with febrile urinary tract infection or bacteriuria. AJR Am J Roentgenol 1987, 148(3):483-6.
273. Roberts JA. Experimental pyelonephritis in the monkey. III. Pathophysiology of ureteral malfunction induced by bacteria. Invest Urol 1975; 13:117-20.
274. Lebowitz RL, Mandell J. Urinary tract infection in children: putting radiology in its place. Radiology 1987; 165(1):1-9.
275. Stokland E, Hellstrom M, Jacobsson B, Jodal U, Sixt R. Renal damage one year after first urinary tract infection: role of dimercaptosuccinic acid scintigraphy. J Pediatr 1996; 129(6):815-20.
276. Jakobsson B, Svensson L. Transient pyelonephritic changes on 99m-technetium-dimercaptosuccinic acid scan for at least five months after infection. Acta Paediatr 1997; 86(8):803-7.
277. International Reflux Committee. Medical versus surgical treatment of primary, vesicoureteral reflux. Pediatrics 1981; 67:392.
278. Cleveland RH, Constantinou C, Blickman J et al. Voiding cysoturethrography in children: value of digital fluoroscopy in reducing radiation dose. Am J Radiol 1991; 158:137.
279. Diamond DA, Kleinman PK, Spevak M et al. The tailored low-dose fluoroscopic voiding cystogram for fmilial reflux screening. J Urol 1996; 155:681-2.
280. Conway JJ, King LR, Belman AB. Detection of vesicoureteral reflux with radionuclide: a comparison study with roentgenographic cystography. AJR Am J Roentgenol 1972; 115:720.
281. Nasrallah PF, Sreeramulu N, Crawford J. Clinical applications of nuclear cystography. J Urol 1982; 128:550.
282. Jaya G, Bal CS, Padhy AK. Radionuclide studies in the evaluation of urinary tract infections in children. Indian Pediatr 1996; 33:635-40.
283. Saraga M, Stanicic A, Markovic V. The role of direct radionuclide cystography in the evaluation of vesicoureteral reflux. Scand J Urol Nephrol 1996; 30: 367-71.
284. Willi UV, Treves ST. Radionuclide Voiding Cystography. New York: Springer-Verlag, 1985: 105-20.
285. Majd M, Kass EJ, Belman AB. The accuracy of the indirect (intravenous) radionuclide cystogram in children. J Nucl Med 1983; 24:23.
286. De Sadeleer C, De Boe V, Keuppens F et al. How good is technetium-99m mercaptoacetyltriglycine indirect cystography? Eur J Nucl Med 1994; 21:223-7.
287. Majd M, Kass EJ, Belman AB. Radionuclide cystography in children: comparison of direct (retrograde) and indirect (intravenous) techniques. Am Radiol 1985; 28:322-8.
288. Kangarloo H, Gold RH, Fine RN, Diament MJ, Boechat MI. Urinary tract infection in infants and children evaluated by ultrasound. Radiology 1985; 154(2):367-73.
289. Horgan JG, Rosenfeld NS, Weiss RM et al. Is renal ultrasound a reliable indicator of nonobstructed duplication anomaly? Pediatr Radiol 1984; 14:388.
290. Jequier S, Forbes PA, Negrady MB. The value of ultrasound as a screening procedure in first documented urinary tract infections in children. J Ultrasound Med 1985; 4:393.
291. Leonidas JC, McCauley RG, Klauber GC, Fretzayas AM. Sonography as a substitute for excretory urography in children with urinary tract infection. AJR Am J Roentgenol 1985; 144(4):815-19.
292. Majd M. Nuclear medicine in pediatric urology. In: Clinical Pediatric Urology, 3rd edn. Philadelphia: WB Saunders, 1992.
293. Mucci B, Macguire B. Does routine ultrasound have a role in the investigation of children with urinary tract infection? Clin Radiol 1994; 49:324-5.
294. Alon US, Ganapathy S. Should renal ultrasonography be done routinely in children with first urinary tract infection? Clin Pediatr 1999; 38:21-5.
295. Ben-Ami T, Rozin M, Hertz M. Imaging of children with urinary tract infection: a tailored approach. Clin Radiol 1989; 40:64.
296. Blickman JG, Taylor GA, Lebowitz RL. Voiding cystourethrography: the initial radiologic study in children with urinary tract infection. Radiology 1985; 156(3): 659-62.
297. Rushton HG. Genitourinary infections: nonspecific infections. In: Kelalis PP, King LR, Belman AB, eds. Clinical Pediatric Urology, 3rd edn. Philadelphia: WB Saunders, 1992.
298. Hansson S, Jodal U, Noren L, Bjure J. Untreated bacteriuria in asymptomatic girls with renal scarring. Pediatr 1989; 84:964-8.
299. Mingin GC, Hinds A, Nguyen HT, Baskin LS. Children with a febrile urinary tract infection and a negative radiologic workup: factors predictive of recurrence. Urology 2004; 63(3):562-5.
300. Cohen RA, Rushton HG, Belman AB et al. Renal scarring and vesicoureteral reflux in children with myelodysplasia. J Urol 1990; 144:541-54.
301. Ottolini MAC, Schaer CM, Rushton HG et al. Relationship of asymptomatic bacilluria and renal scarring in children with neuropathic bladders who are practicing intermittent catheterization. J Pediatr 1995; 127:368.
302. Bisset GS III, Strife JL, Dunbar JS. Urography and voiding cystourethrography: findings in girls with urinary tract infection. AJR Am J Roentgenol 1987; 148(3):479-82.
303. Skoog SJ, Belman AB. A nonsurgical approach to the management of primary vesicoureteral reflux. J Urol 1987; 138(4 pt 2):941-6.
304. Bellinger MF, Duckett JW. Vesicoureteral reflux: a comparison of non-surgical and surgical management. In: Contributions to Nephrology. Reflux Nephropathy Update 1983, Vol. 39; 1984.
305. Burge DM, Griffiths MD, Malone PS, Atwell JD. Fetal vesicoureteral reflux: outcome following conservative postnatal management. J Urol 1992; 148(5 Pt 2):1743-5.
306. Crabbe DC, Thomas DF, Gordon AC et al. Use of 99mtechnetium-dimercaptosuccinic acid to study patterns of renal damage associated with prenatally detected vesicoureteral reflux. J Urol 1992; 148(4):1229-31.
307. Sheridan M, Jewkes F, Gough DCS. Reflux nephropathy in the 1st year of life-the role of infection. Pediatr Surg Int 1991; 6:214.
308. Anderson PAM, Rickwood AMK. Features of primary vesicoureteric reflux detected by prenatal sonography. Br J Urol 1991; 67:267.
309. Najmaldin A, Burge DM, Atwell TD. Reflux nephropathy secondary to intrauterine vesicoureteric reflux. J Pediatr Surg 1990; 25:387-90.
310. Gordon I. Urinary tract infection in paediatrics: the role of diagnostic imaging. Br J Radiol 1990; 63(751):507-11.
311. Ransley PG, Risdon RA. Reflux in renal scarring. Br J Radiol 1978; 51 (Suppl 14):1.
312. Ransley PG. Intrarenal reflux: anatomical, dynamic and radiological studies. Part I. Urol Res 1977; 5:61.
313. Smellie JM, Preece MA, Paton AM. Somatic growth in girls receiving low dose prophylactic co-trimoxazole. BMJ Clin Res Ed 1983; 287(6396):875.
314. Rushton HG. Reflux versus nonreflux pyelonephritis. In: Gonzales ET, Paulson DF, eds. Problems in Urology. Advances in Pediatric Urology, Vol. 8, Philadelphia: WB Saunders, 1994.
315. Winberg J, Bollgren I, Kallenius G, Mollby R, Svenson SB. Clinical pyelonephritis and focal renal scarring. A selected review of pathogenesis, prevention, and prognosis. Pediatr Clin North Am 1982; 29(4):801-14.
316. Winter AL, Hardy BE, Alton DJ, Arbus GS, Churchill BM. Acquired renal scars in children. J Urol 1983; 129(6):1190-4.
317. Edwards D, Normand IC, Prescod N, Smellie JM. Disappearance of vesicoureteric reflux during long-term prophylaxis of urinary tract infection in children. BMJ 1977; 2(6082):285-8.
318. Mackie GG, Stephens FD. Duplex kidneys: a correlation of renal dysplasia with position of the ureteral orifice. J Urol 1975; 114:2743.
319. Sommer JT, Stephens FD. Morphogenesis of nephropathy with partial ureteral obstruction and vesicoureteric reflux. J Urol 1981; 125:67.
320. Filly R, Friedland GW, Govan DE, Fair WR. Development and progression of clubbing and scarring in children with recurrent urinary tract infections. Radiology 1974; 113(1):145-53.
321. Merrick MV, Uttley WS, Wild SR. The detection of pyelonephritic scarring in children by radioisotope imaging. Br J Radiol 1980; 53(630):544-56.
322. Goldraich NP, Ramos DL, Goldraich JH et al. Urography versus DMSA scan in children with vesicoureteral reflux. Pediatr Nephrol 1987; 3:1.
323. Monsour M, Azmy AF, MacKenzie JR. Renal scarring secondary to vesicoureteric reflux. Critical assessment and new grading. Br J Urol 1987; 32(5):375-8.
324. Elison BS, Taylor D, Van der Wall H et al. Comparison of DMSA scintigraphy with intravenous urography for the detection of renal scarring and its correlation with vesicoureteral reflux. J Urol 1992; 69:294-302.
325. Farnsworth RH, Rossleigh MA, Leighton DM, Bass SJ, Rosenberg AR. The detection of reflux nephropathy in infants by 99mtechnetium dimercaptosuccinic acid studies. J Urol 1991; 145(3):542-6.
326. Stokland E, Hellstrom M, Jacobsson B, Jodal U, Sixt R. Evaluation of DMSA scintigraphy and urography in assessing both acute and permanent renal damage in children. Acta Radiol 1998; 4:447-52.
327. Arnold AJ, Brownless SM, Carty HM, Rickwood AM. Detection of renal scarring by DMSA scanning-an experimental study. J Pediatr Surg 1990; 25(4):391-3.
328. Rosenberg AR, Rossleigh MA, Brydon MP et al. Evaluation of acute urinary tract infection in children by dimercaptosuccinic acid scintigraphy: a prospective study. J Urol 1992; 148(5 Pt 2):1746-9.
329. Wallin L, Bajc M. Typical technetium dimercaptosuccinic acid distribution patterns in acute pyelonephritis. Acta Paediatr 1993; 82(12):1061-5.
330. Stokland E, Hellstrom M, Hansson SA et al. Reliability of ultrasonography in identification of reflux nephropathy in children. BMJ 1994; 309(6949):235-9.
331. Jakobsson B, Berg U, Svensson L. Renal scarring after acute pyelonephritis. Arch Dis Child 1994; 70:111.
332. Jakobsson B, Nolstedt L, Svensson L, Soderlundh S, Berg U. 99mTc-dimercaptosuccinic acid (DMSA) in the diagnosis of acute pyelonephritis in children: relation to clinical and radiological findings. Pediat Nephrol 1992; 6:328-34.
333. McGuire EJ, Woodside JR. Diagnostic advantages of fluoroscopic monitoring during urodynamic evaluation. J Urol 1981; 125(6):830-4.
334. Londe S. Cause of hypertension in the young. Pediatr Clin North Am 1978; 25:55-65.
335. Still JL, Cottom D. Severe hypertension in childhood. Arch Dis Child 1967; 42:34.
336. Gill DG, Mendes da Costa B, Cameron JS et al. Analysis of 100 children with severe and persistent hypertension. Arch Dis Child 1976; 51:951.
337. Wanner C, Lusher T, Groth H et al. Unilateral parenchymatous kidney disease and hypertension: results of nephrectomy and medical treatment. Nephron 1985; 41:250-7.
338. Goonasekera CD, Shah V, Wade AM, Barratt TM, Dillon MJ. 15-year follow-up of renin and blood pressure in reflux nephropathy. Lancet 1996; 347(9002):640-3.
339. Jacobson SH, Eklof O, Eriksson CG et al. Development of hypertension and uraemia after pyelonephritis in childhood: twenty-seven year follow-up. BMJ 1989; 299:703.
340. Zhang Y, Bailey RR. A long term follow up of adults with reflux nephropathy. N Z Med J 1995; 108:142-4.
341. Smellie JM, Normand ICS. Reflux nephropathy in childhood. In: Reflux Nephropathy. New York: Masson, 1979:14-20.
342. Bailey RR, McRae CU, Maling TMJ et al. Renal vein renin concentration in the hypertension of unilateral reflux nephropathy. J Urol 1978; 120:21.
343. Bailey RR, Lynn KL, McRae CU. Unilateral reflux nephropathy and hypertension. Contrib Nephrol 1984; 39:116.
344. Savage JM, Koh CT, Shah V, Barrett TM, Dillon MJ. Five-year prospective study of plasma renin activity and blood pressure in patients with longstanding reflux nephropathy. Arch Dis Child 1987; 62:678.
345. Jacobson SH, Kjellstrend CM, Lins LE. Role of hypervolaemia and renin in the blood pressure control of patients with pyelonephritic renal scarring. Acta Med Scand 1988; 224:47.
346. Holland NH, Kotchen T, Bhathena D. Hypertension in children with chronic pyelonephritis. Kidney Int 1975; 8:S243.
347. Luscher TF, Wanner C, Hauri D, Siegenthaler W, Vetter W. Curable renal parenchymatous hypertension: current diagnosis and management. Cardiology 1985; 72 (Suppl):33-45.
348. Disney APS. Reflux nephropathy in Australia and New Zealand: prevalence, incidence and management-1975-1989. Second CJ Hodson Symposium on Reflux Nephropathy. Christ Church, New Zealand: Design Printing Services, 1991:53-9.
349. Sreenarasimhaiah S, Hellerstein S. Urinary tract infections per se do not cause end-stage kidney disease. Pediatr Nephrol 1998; 12:210-113.
350. Zimmerman SW, Uehling DT, Burkholder PM. Vesicoureteral reflux nephropathy. Evidence for immunologically mediated glomerular injury. Urology 1973; 2:534-8.
351. Torres VE, Velosa JA, Holley KE Progression of vesicoureteral reflux nephropathy. Ann Intern Med 1980; 92:776-84.
352. Bhathena DB, Weiss JH, Holland NH et al. Focal and segmental glomerulosclerosis in reflux nephropathy (chronic pyelonephritis). Am J Med 1980; 68:886.
353. Kincaid-Smith P. Glomerular lesions and atrophic pyelonephritis in reflux nephropathy. Kidney Int 1975; 8:S-81.
354. Stamey TA, Fair WR, Timothy MM et al. Serum versus urinary antimicrobial concentrations in cure of urinarytract infections. N Engl J Med 1974; 291(22):1159-63.
355. Eichenwald HF. Some aspects of the diagnosis and management of urinary tract infection in children and adolecents. Pediatr Infect Dis J 1986; 5:760.
356. Hansson S, Caugant D, Jodal U, Svanborg-Eden C. Untreated asymptomatic bacteriuria in girls: I.-Stability of urinary isolates. BMJ 1989; 298:853-5.
357. White RHR. Management of urinary tract infection. Arch Dis Child 1987; 62:421.
358. Wettergren B, Hellstrom M, Stokland E, Jodal U. Six year follow up of infants with bacteriuria on screening. BMJ 1990; 301:845-8.
359. Bergstrom T, Lincoln K, Orskov F et al. Studies of urinary tract infections in infancy and children. VIII Reinfection vs relapse in recurrent urinary tract infections: evaluation by means of identification of infecting organisms. J Pediatr 1967; 72:13.
360. McGeachie J. Recurrent infection of the urinary tract: reinfection or recrudescence? BMJ 1966; 1:952.
361. Hansson S, Jodal U, Noren L. Treatment vs. nontreatment of asymptomatic bacteriuria in girls with renal scarring. Host-Parasite Interactions in Urinary Tract Infections. Chicago: University of Chicago Press, 1989:289-91.
362. Savage DCL, Howie G, Adler K, Wilson MI. Controlled trial of therapy in covert bacteriuria in childhood. Lancet 1975; 1:358-61.
363. Newcastle Asymptomatic Bacteriuria Research Group. Asymptomatic bacteriuria in school children in Newcastle-upon-Tyne: a 5-year followup. Arch Dis Child 1981; 56:585-92.
364. Russo RM, Gururaj VJ, Laude TA, Rajkumar SV, Allen JE. The comparative efficacy of cephalexin and sulfisoxazole in acute urinary tract infection in children. Clin Pediatr 1991; 16(1):83-4.
365. Craig JC, Irwig LM, Knight JF, Sureshkumar P, Roy LP. Symptomatic urinary tract infection in preschool Australian children. J Paediatr Child Health 1998; 34:154-9.
366. Al Roomi LG, Sutton AM, Cockburn F et al. Amoxycillin and clavulanic acid in the treatment of urinary infection. Arch Dis Child 1984; 59(3):256-9.
367. Ruberto U, D'Eufemia P, Martino F, Giardini O. Amoxycillin and clavulanic acid in the treatment of urinary tract infections in children. J Int Med Res 1989; 17:168-71.
368. Barry HC, Ebell MH, Hickner J. Evaluation of suspected urinary tract infection in ambulatory women: a cost-utility analysis of office-based strategies. J Family Pract 1997; 44(1):49-60.
369. Hooper DC, Wolfson TS, Ng EY et al. Mechanism of action and resistance to ciprofloxacin. Am J Med 1987; 82(Suppl 4A):12.
370. Schluter G. Toxicology of ciprofloxacin. First International Ciprofloxacin Workshop, Proceedings 1986; 61.
371. Bouissou H, Caujolle D, Caujolle F, Milhand G. [Cartilaginous tissue and nalidixic acid]. C R Acad Sci Hebd Seances Acad Sci D 1978; 286(23):1743-6. [French]
372. Schaad UB, Wedgwood-Krucko J. Nalidixic acid in children: a retrospective matched controlled study for cartilage toxicity. Infection 1978; 15:165.
373. Ball P. Ciprofloxacin: an overview of adverse experiences. J Antimicrob Chemother 1986; 18(Suppl D):187.
374. Moffatt M, Embree J, Grimm P, Law B. Short-course antibiotic therapy for urinary tract infections in children. A methodological review of the literature. Am J Dis Child 1988; 142(1):57-61.
375. Avner ED, Ingelfinger JR, Herrin JT et al. Single-dose amoxicillin therapy of uncomplicated pediatric urinary tract infections. J Pediatr 1983; 102(4):623-7.
376. McCracken GH Jr, Ginsburg CM, Namasonthi V, Petruska M. Evaluation of short-term antibiotic therapy in children with uncomplicated urinary tract infections. Pediatrics 1981; 67(6):796-801.
377. Khan AJ. Efficacy of single-dose therapy of urinary tract infection in infants and children: a review. J Nat Med Assoc 1994; 86:690-6.
378. Madrigal G, Odio CM, Mohs E et al. Single dose antibiotic therapy is not as effective as conventional regimens for management of acute urinary tract infections in children. Pediatr Infect Dis J 1988; 7:316.
379. Petersen KE. Short term treatment of acute urinary tract infections in girls. Copenhagen Study Group of Urinary Tract Infections in Children. Scand J Infect Dis 1991; 23:213-20.
380. Ruberto U, D'Eufemia P, Ferretti L, Giardini O. Effect of 3-vs 10-day treatment of urinary tract infections. J Pediatr 1984; 104(3):483-4.
381. Smellie JM, Poulton A, Prescod NP. Retrospective study of children with renal scarring associated with reflux and urinary infection. BMJ 1994; 308(6938):1193-6.
382. Dagan R, Einhorn M, Lang R et al. Once daily cefixime compared with twice daily trimethoprim/sulfamethoxazole for urinary tract infection in infants and children. Pediatr Infect Dis J 1992; 11:198-203.
383. Hoberman A, Wald ER, Hickey RW et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 1999; 104:74-86.
384. Cornu C, Cochat P, Collet JP et al. Survey of the attitudes to management of acute pyelonephritis in children. Pediatr Nephrol 1994; 8:275-7.
385. Helwig H. Therapeutic strategies for urinary tract infections in children. Infection 1994; 22(S):12.
386. Belman AB. A perspective on vesicoureteral reflux. Urol Clin North Am 1995; 22(1):139-50.
387. Austenfeld MS, Snow BW. Complications of pregnancy after reimplantation for vesicoureteral reflux. J Urol 1988; 140:1103.
388. Mansfield JT, Snow BW, Cartwright PC, Wadsworth K. Complications of pregnancy in women after childhood reimplantation for vesicoureteral reflux: an update with 25 years of followup. J Urol 1995; 154(2 Pt 2):787-90.
389. Bukowski TP, Betrus GG, Aquilina JW, Perlmutter AD. Urinary tract infections and pregnancy in women who underwent antireflux surgery in childhood. J Urol 1998; 159(4):1286-9.
390. Stansfeld JM. Duration of treatment for urinary tract infections in children. BMJ 1975; 3(5975):65-6.
391. Belman AB. Clinical significance of cystitis cystica in girls: results of a retrospective study. J Urol 1978; 127:7474.
392. Smellie JM, Katz G, Gruneberg RN. Controlled trial of prophylactic treatment in childhood urinary-tract infection. Lancet 1978; 2(8082):175-8.
393. Lidin-Janson G, Jodal U, Lincoln K. Trimethoprim-och nitrofurantoin for profylax mot UVI hos barn. Recip Reflex 1980; Suppl VI:38.
394. Smellie JM, Bantock HM, Thompson BD. Co-trimoxazole and the thyroid [Letter]. Lancet 1982; 2(8289):96.
395. Brendstrup L, Hjelt K, Petersen KE et al. Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in childhood. A randomized, double-blind study. Acta Paediatr Scand 1990; 79:1225-34.
396. Harding GK, Ronald AR, Boutros P, Lank B. A comparison of trimethoprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys. Can Med Assoc J 1975; 112(13 Spec No):9-12.
397. Hori C, Hiraoka M, Tsukahara H et al. Intermittent trimethoprim-sulfamethoxazole in children with vesicoureteral reflux. Pediatr Nephrol 1997; 11:328-30.
398. Smith EM, Elder JS. Double antimicrobial prophylaxis in girls with breakthrough urinary tract infections. Urology 1994; 43:708-12.
399. Rote AR, Bauer SB, Retik AB. Renal abscess in children. J Urol 1978; 119:254.
400. Vachvanichsanong P, Dissaneewate P, Patrapinyokul S, Pripatananont C, Sujijantararat P. Renal abscess in healthy children: report of three cases. Pediatr Nephrol 1992; 6(3):273-5.
401. Timmons JW, Perlmutter AD. Renal abscess: a changing concept. J Urol 1976; 115:299.
402. Koehler PR. The roentgen diagnosis of renal inflammatory masses-special emphasis on angiographic changes. Radiology 1974; 112:257-66.
403. Hopkins GB, Hall RL, Mende CW. Gallium-67 scintigraphy for the diagnosis and localization of perinephric abscesses. J Urol 1976; 115:126.
404. Kumar B, Coleman RE, Anderson PO. Gallium citrate Ga-67 imaging in patients with suspected inflammatory processes. Arch Surg 1975; 110:1237.
405. Wippermann CF, Schofer O, Beetz R et al. Renal abscesses in childhood: diagnostic and therapeutic progress. Pediatr Infect Dis J 1991; 10(6):446-50.
406. Schiff M Jr, Glickman M, Weiss RM et al. Antibiotic treatment of renal carbuncle. Ann Intern Med 1977; 8:305.
407. Steele BT, Petrou C, de Maria J. Renal abscesses in children. Urology 1990; 36(4):325-8.
408. Brandeis JM, Baskin LS, Kogan BA, Wara D, Corenbaum A. Recurrent Staphylococcus aureus renal abscess in a child positive for the human immunodeficiency virus. Urology 1995; 46(2):246-8.
409. Gomber S, Revathi G, Krishna A, Gupta A. Perinephric abscess (presenting as abdominal pain) due to Listeria monocytogenes. Ann Trop Paediatr 1998; 18(1):61-2.
410. Sugar EC, Firlit CF. Urodynamic biofeedback: a new therapeutic approach for childhood incontinence/infection (vesical voluntary sphincter dyssynergia). J Urol 1982; 128(6):1253-8.
411. Yazbeck S, Schick E, O'Regan S. Relevance of constipation to enuresis, urinary tract infection and reflux. A review. Eur Urol 1987; 13(5):318-21.
412. Weinberg AC, Boyd SD. Short-course chemotherapy and role of surgery in adult and pediatric genitourinary tuberculosis. Urol 1988; 31:95.
413. Smith MHD, Marquis IR. Tuberculosis and other mycobacterial infections. In: Feigin RD, Cherry ID (eds) Textbook of Pediatric Infectious Diseases, Vol 1. Philadelphia: WB Saunders, 1981.
414. Cotran RS, Kumar V, Robbins SL. Robbins Pathologic Basis of Disease, 4th ed. Philadelphia: WB Saunders, 1989. pp 374-80.
415. Cinman AC. Genitourinary tuberculosis. Urol 1982; 20:353.
416. Cos LR, Cockett ATK. Genitourinary tuberculosis revisited. Urol 1982; 20:111.
417. García-Rodriguez IA, García Sanchez IE, Gómez-García AC et al. Extrapulmonary tuberculosis in a university hospital in Spain. Eur J Epidemiol 1989; 5:154.
418. Murphy DM, Fallon B, Lane V et al. Tuberculosis stricture of the ureter. Urol 1982; 20:382.
419. Ehrlich RM, Lattimer JK. Urogenital tuberculosis in children. Urol 1971; 105:461.
420. Singh A, Fazal AR, Sinha SK et al. Tuberculosis vesicovaginal fistula in a child. Br J Urol 1988; 62:615.
421. Kenney M, Loechel AB, Lovelock FJ. Urine cultures in tuberculosis. Am Rev Respir Dis 1960; 82:564.
422. Lattimer JK, Vasquez G, Wechler H. New drugs for treatment of genitourinary tuberculosis: a comparison of efficacy. J Urol 1960; 83:493.
423. Hartmann GW, Segura JW, Hattery RR. Infectious diseases of the genitourinary tract. In: Witten DM, Myers GH Jr, Utz DC (eds) Emmett's Clinical Urography: An Atlas and Textbook of Roentgenologic Diagnosis, Vol 2, 4th ed. Philadelphia: WB Saunders 1977, 898-918.
424. Gow JG. Genitourinary tuberculosis. In: Walsh PC, Critter RF, Perlmutter AD et al (eds) Campbell's Urology, Vol 1, 5th ed. Philadelphia: WB Saunders 1986, 1037-69.
425. American Academy of Pediatrics. Report of the Committee on Infectious Diseases, 21st ed. EIK Grove Village, IL: American Academy of Pediatrics, 1988.
426. Glassroth I, Robins AG, Snider DE Jr. Letter to the editor. N Engl J Med 1980; 303:940.
427. Weschler H, Lattimer JK. An evaluation of the current therapeutic regimen for renal tuberculosis. J Urol 1975; 113:760.
428. Fox W. The chemotherapy of pulmonary tuberculosis: a review. Chest 1979; 76:785.
429. Gow JG, Barbosa S. Genitourinary tuberculosis: a study of 1117 cases over a period of 34 years. Br J Urol 1984; 56:449.
430. Shaaf HS, Smith I, Donald PR et al. Tuberculosis presenting in the neonatal period. Clin Pediatri (Phila) 1989; 28:474.
431. Flechner SM, Gow JG. Role of Rephrectomy in the treatment of non-functioning or very poorly functioning unilateral tuberculous kidney. J Urol 1980; 123:822.
432. Wong SH, Lau WY. The surgical management of nonfunctioning tuberculous kidneys. J Urol 1980; 124:187.
433. Zinman L, Libertino IA. Antirefluxing ileocecal conduit. Urol Clin North Am 1980; 7:503.
434. Yazaki T, Ishikawa S, Ogawa Y et al. Xanthogranulomatous pyelonephritis in childhood: case report and review of English and Japanese literature. J Urol 1982; 127(1):80-3.
435. Watson AR, Marsden HB, Cendron M et al. Renal pseudotumors caused by xanthogranulomatous pyelonephritis. Arch Dis Child 1982; 57:635.
436. Goodman TR, McHugh K, Lindsell DR. Paediatric xanthogranulomatous pyelonephritis. Int J Clin Pract 1998; 52(1):43-5.
437. Schulman CC, Denis R. Xanthogranulomatous pyelonephritis in childhood [Letter]. J Urol 1977; 117:398.
438. Bagley FH, Stewart AM, Jones PF. Diffuse xanthogranulomatous pyelonephritis in children: an unrecognized variant. J Urol 1977; 118:434.
439. Subramanyam BR, Megibow AJ, Raghavendra BN et al. Diffuse xanthogranulomatous pyelonephritis: analysis by computed tomography and sonography. Urol Radiol 1982; 4:5.
440. Feingold DS. Antimicrobial chemotherapeutic agents: the nature of their action in selected toxicity. N Engl J Med 1963; 269:900.
441. Behrman RF, Vaughan VCI. Nelson Textbook of Padiatrics, 13th edn. Philadelphia: WB Saunders, 1987.
442. American Medical Association. AMA Drug Evaluations. Chicago: AMA, 1971.
443. Stamey TA, Condy M, Mihara G. Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections: biologic effects on the vaginal and rectal flora. N Eng J Med 1977; 296:780.
444. Vaisanen V, Lounatmaa R, Korhonen TK. Effects of sublethal concentrations of antimicrobial agents on the hemagglutination, adhesion, and ultrastructure of pyelonephritogenic Escherichia coli strains. Antimicrob Agents Chemother 1982; 22:120-7.
445. Asmar BI, Maqbool S, Dajani AS. Hematologic abnormalities after oral trimethoprim-sulfamethoxazole therapy in children. Am J Dis Child 1981; 135(12): 1100-3.
446. Kunin CM. Detection, Prevention and Management of Urinary Tract Infections, 4th edn. Philadelphia: Lea and Febiger, 1987.
447. Drug Newsletter. Facts and Comparisons Div. 8:56 edition. St Louis: JB Lippincott, 1989.
448. Kurnin GD. Clinical nephrotoxicity of tobramycin and gentamicin: a prospective study. JAMA 1980; 244:1808.
449. Stamey TA, Bragonje J. Resistance to nalidixic acid. A misconception due to underdosage. JAMA 1976; 236:1857-60.
450. Ross R Jr, Conway GF. Hemorrhagic cystitis following an accidental overdosage of methenamine mandelate. Am J Dis Child 1970; 119:86.